Skip to content
Review Open access

Incidental detection of maternal malignancy in non-reportable results from non-invasive prenatal testing: experience in Hong Kong and literature review.

Oct 2026 · Hong Kong medical journal = Xianggang yi xue za zhi · 0 citations
Medicine

TL;DR

Although rare, occult maternal malignancy represents 3.82% of non-reportable NIPT results and should be included in pre-test counselling and may warrant early oncological evaluation.

Abstract

INTRODUCTION Non-invasive prenatal testing (NIPT) for fetal aneuploidy occasionally yields non-reportable results due to persistent 'noisy' signals, which may indicate occult maternal malignancy. This study investigated the clinical and genetic implications of non-reportable NIPT results, focusing on multiple chromosomal aberrations associated with maternal malignancy, with the goal of developing standardised management protocols for pregnant women with such suspicious NIPT results.

Methods

From 2020 to 2023, women with persistent non-reportable NIPT results were identified and followed up in Hong Kong. Cancer cases were analysed for clinical history and chromosomal patterns. Incidental cancer detection rates were calculated and compared with literature reports. Tag Z-score chromosomal abnormalities were compared between cancer and non-cancer groups; the corresponding sensitivity and specificity were calculated.

Results

Among 84 446 NIPT tests, 151 (0.18%) showed persistent noisy signals. Of 131 patients with follow-up data, five (3.82%) were diagnosed with maternal malignancy; the overall incidental detection rate was 0.006% (5 of 84 446). Although three women delivered healthy babies, most presented with late-stage cancer confirmed by imaging and biopsy. All five cases exhibited ≥3 chromosomal aberrations on repeat NIPT; chromosome 18 was consistently involved. Univariate analysis revealed significant differences in Tag Z-score frequencies for chromosomes 18 (P=0.026) and 21 (P=0.029) between cancer and non-cancer groups. A clinical flowchart was developed to guide management of patients with multiple aberrations.

Conclusion

Although rare, occult maternal malignancy represents 3.82% of non-reportable NIPT results. This risk should be included in pre-test counselling and may warrant early oncological evaluation. Whole-body magnetic resonance imaging should be considered to facilitate cancer diagnosis.

Read PDF

Similar papers

Open access Oct 2026

Prenatal diagnostic outcomes and positive predictive values in 1,326 pregnancies with high-risk non-invasive prenatal testing results

Objective To investigate the prenatal diagnostic outcomes of pregnant women with high-risk non-invasive prenatal testing (NIPT) results and to explore factors influencing the positive predictive value (PPV) of NIPT. Methods Clinical data from 1,326 pregnant women with high-risk NIPT results who underwent invasive prena...

Run-Xuan Du, Bin-Xiu Zhao, Xue-Dong Shi et al. · 0 citations
Open access Oct 2026

Causes of discordance between noninvasive prenatal testing and fetal chromosomal status: a 10-year cohort study of 97, 743 cases

Background Noninvasive prenatal testing (NIPT) has been widely adopted for screening common fetal chromosomal aneuploidies, yet discordance between NIPT results and true fetal karyotypes remains a critical challenge limiting its clinical utility. Methods We retrospectively analyzed 97, 743 pregnant women who underwent...

Hai-Mei Qi, Hai-Jun Chen, Xian-Ping Yuan et al. · 0 citations
Open access Oct 2026

Performance of non-invasive prenatal screening for 15q11q13 copy number variations in a cohort of 90,693 pregnancies

Background Deletions and duplications within the 15q11q13 chromosomal region are associated with Prader-Willi syndrome, Angelman syndrome, and 15q11q13 duplication syndrome. However, prenatal ultrasound findings were unremarkable in the majority of affected fetuses. The aim of this study was to evaluate the efficacy of...

Di-Yu Chen, Liang Hu, Hong-Yan Niu et al. · 0 citations
Open access Sep 2026

Multimodal genomic testing in prenatal diagnosis: incremental diagnostic contribution of chromosomal microarray and exome sequencing, real-world NIPT confirmation rates and pregnancy outcomes in 120 consecutive amniocenteses from northeastern Türkiye — a retrospective cohort study

Most evidence on chromosomal microarray analysis (CMA) and exome sequencing (ES) in prenatal diagnosis comes from high-volume centres. We evaluated the incremental diagnostic contribution of additional testing modalities, non-invasive prenatal testing (NIPT) confirmation rates and pregnancy outcomes at a regional centr...

Çağrı Doğan, Selçuk Atalay, Hakan Timur · 0 citations
Open access Oct 2026

Study on copy number variant detection results of 472 fetuses with non-structural ultrasound abnormalities in non-advanced age pregnant women and the correlation with adverse obstetric history

To investigate copy number variant (CNV) results in 472 fetuses with non-structural ultrasound abnormalities among pregnant women under 35 years, and analyze the association between adverse obstetric history and pathogenic/likely pathogenic (P/LP) CNVs and variants of uncertain significance (VUS). A total of...

Li-Fang Lin, He-Ming Wu, Zhi-Yuan Zheng et al. · 0 citations
Oct 2026

Real-World Performance and Screening Outcomes of Non-invasive Prenatal Testing in Jordanian Pregnant Women

Non-invasive prenatal testing (NIPT) is a method that uses cell-free fetal DNA in maternal blood sample to detect common fetal chromosomal aneuploidies. It has been recognized as the most clinically robust screening method and widely used worldwide. Although clinical validation and implementation of NIPT studies have c...

Yousef Al-Hajaya · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.